Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PF-543 (hydrochloride)

PF-543 hydrochloride (Sphingosine Kinase 1 Inhibitor II hydrochloride) is a potent, selective, reversible and sphingosine-competitive SPHK1 inhibitor with an IC50 of 2 nM and a Ki of 3.6 nM. PF-543 hydrochloride is >100-fold selectivity for SPHK1 over SPHK2. PF-543 hydrochloride is an effective potent inhibitor of sphingosine 1-phosphate (S1P) formation in whole blood with an IC50 of 26.7 nM. PF-543 hydrochloride induces apoptosis, necrosis, and autophagy[1][2][3].

Product Specifications

CAS Number

[1706522-79-3]

Product Name Alternative

Sphingosine Kinase 1 Inhibitor II (hydrochloride)

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

Apoptosis; Autophagy; LPL Receptor; SphK

Type

Reference compound

Related Pathways

Apoptosis; Autophagy; GPCR/G Protein; Immunology/Inflammation

Applications

Cancer-Kinase/protease

Field of Research

Cancer; Inflammation/Immunology; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/pf-543-hydrochloride.html

Solubility

10 mM in DMSO

Smiles

[H]Cl.O=S(C1=CC=CC=C1)(CC2=CC(C)=CC(OCC3=CC=C(CN4[C@@H](CO)CCC4)C=C3)=C2)=O

Molecular Formula

C27H32ClNO4S

Molecular Weight

502.07

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Schnute ME, et al. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. Biochem J. 2012 May 15;444 (1) :79-88.|[2]MacRitchie N, et al. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension. Cell Signal. 2016 Aug;28 (8) :946-55.|[3]Hamada M, et al. Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells. Cell Death Discov. 2017 Aug 14;3:17047.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

SphK1

Citation 01

FASEB J. 2024 Jan 31;38 (2) :e23417.|Arch Pharm Res. 2025 Aug;48 (7-8) :798-813.|Cancer Commun (Lond) . 2025 Jul 16.|Cancer Sci. 2020 Jul;111 (7) :2259-2274.|Cell Death Dis. 2024 Aug 1;15 (8) :552.|Curr Res Pharmacol Drug Discov. 2025 Jan 9:8:100212.|Dig Dis Sci. 2025 Jun 5.|Environ Pollut. 2025 Jul 16:383:126846.|Hum Cell. 2020 Jan;33 (1) :57-66.|Inflammation. 2021 Dec;44 (6) :2170-2179.|Pflugers Arch. 2025 Jun;477 (6) :815-826.|Phytomedicine. 2025 Sep 19:148:157271.|Phytother Res. 2025 Aug;39 (8) :3419-3431.|Ren Fail. 2025 Dec;47 (1) :2568972.|Sci China Life Sci. 2022 Feb;65 (2) :341-361.|Sci Rep. 2020 Aug 14;10 (1) :13834.|Mol Cell. 2020 Mar 19;77 (6) :1294-1306.e5.
Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Human ADA1B full length protein-synthetic nanodisc
MBS189935-01 0.01 mg

Human ADA1B full length protein-synthetic nanodisc

Ask
View Details
Human ADA1B full length protein-synthetic nanodisc
MBS189935-02 0.05 mg

Human ADA1B full length protein-synthetic nanodisc

Ask
View Details
Human ADA1B full length protein-synthetic nanodisc
MBS189935-03 0.1 mg

Human ADA1B full length protein-synthetic nanodisc

Ask
View Details
ODF2 Rabbit Monoclonal Antibody
TA423590 100 µL

ODF2 Rabbit Monoclonal Antibody

Ask
View Details
Troponin I (Cardiac) (Biotin)
227220-Biotin 100 µL

Troponin I (Cardiac) (Biotin)

Ask
View Details
DPM1 Rabbit pAb
E45R27672N-100 100 µL

DPM1 Rabbit pAb

Ask
View Details